[1] |
El-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med, 2011, 365(12):1118-1127.
|
[2] |
Zhong JH, Ma L, Li LQ. Postoperative therapy options for hepatocellular carcinoma[J]. Scand J Gastroenterol, 2014, 49(6):649-661.
|
[3] |
Poon RT, Ng IO, Fan ST, et al. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma:a study of a prospective cohort[J]. J Clin Oncol, 2001, 19(12):3037-3044.
|
[4] |
Zhong JH, Li H, Li LQ, et al. Adjuvant therapy options following curative treatment of hepatocellular carcinoma:a systematic review of randomized trials[J]. Eur J Surg Oncol, 2012, 38(4):286-295.
|
[5] |
Barreto Penié J, Cuban Group for the Study of Hospital Malnutrition. State of malnutrition in Cuban hospitals[J]. Nutrition, 2005, 21(4):487-497.
|
[6] |
Andreoli A, De Lorenzo A, Cadeddu F, et al. New trends in nutritional status assessment of cancer patients[J]. Eur Rev Med Pharmacol Sci, 2011, 15(5):469-480.
|
[7] |
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients[J]. Nihon Geka Gakkai Zasshi, 1984, 85(9):1001-1005.
|
[8] |
Jiang N, Deng JY, Ding XW, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer[J]. World J Gastroenterol, 2014, 20(30):10537-10544.
|
[9] |
Tokunaga R, Sakamoto Y, Nakagawa S, et al. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection[J]. Dis Colon Rectum, 2015, 58(11):1048-1057.
|
[10] |
Feng JF, Chen QX. Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma[J]. Ther Clin Risk Manag, 2014(10):1-7.
|
[11] |
Yao ZH, Tian GY, Wan YY, et al. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma[J]. J Cancer Res Clin Oncol, 2013, 139(12):2117-2123.
|
[12] |
Geng Y, Qi Q, Sun M, et al. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer[J]. Eur J Surg Oncol, 2015, 41(11):1508-1514.
|
[13] |
Zhang X, Li C, Wen T, et al. Postoperative prognostic nutritional index predicts survival of patients with hepatocellular carcinoma within Milan criteria and hypersplenism[J]. J Gastrointest Surg, 2017, 21(10):1626-1634.
|
[14] |
Omata M, Lesmana LA, Tateishi R, et al. Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma[J]. Hepatol Int, 2010, 4(2):439-474.
|
[15] |
Chen KL, Liu YH, Li WY, et al. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type[J]. Ann Hematol, 2015, 94(8):1389-1400.
|
[16] |
Watanabe M, Iwatsuki M, Iwagami S, et al. Prognostic nutritional index predicts outcomes of gastrectomy in the elderly[J]. World J Surg, 2012, 36(7):1632-1639.
|
[17] |
Chan AW, Chan SL, Wong GL, et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection[J]. Ann Surg Oncol, 2015, 22(13):4138-4148.
|
[18] |
Ke M, Xu T, Li N, et al. Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria[J]. Oncotarget, 2016, 7(49):81611-81620.
|
[19] |
Okamura Y, Sugiura T, Ito T, et al. The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma[J]. Surg Today, 2017, 47(8):986-993.
|
[20] |
Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting[J]. Immunity, 2004, 21(2):137-148.
|
[21] |
Wu SJ, Lin YX, Ye H, et al. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy[J]. J Surg Oncol, 2016, 114(2):202-210.
|
[22] |
Lin ZX, Ruan DY, Li Y, et al. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection[J]. World J Gastroenterol, 2015, 21(38):10898-10906.
|
[23] |
Li X, Chen ZH, Xing YF, et al. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma[J]. Tumour Biol, 2015, 36(4):2263-2269.
|
[24] |
Limaye AR, Clark V, Soldevila-Pico C, et al. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma[J]. Hepatol Res, 2013, 43(7):757-764.
|